David H. Bollinger

Array ( [id] => 6711562 [patent_doc_number] => 20030171311 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection' [patent_app_type] => new [patent_app_number] => 09/817879 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 83229 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20030171311.pdf [firstpage_image] =>[orig_patent_app_number] => 09817879 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131378 [patent_doc_number] => 20020077308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Methods of treating colitis using STAT-4 anti-sense oligonucleotides' [patent_app_type] => new [patent_app_number] => 09/812028 [patent_app_country] => US [patent_app_date] => 2001-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10656 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077308.pdf [firstpage_image] =>[orig_patent_app_number] => 09812028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6225336 [patent_doc_number] => 20020004490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-01-10 [patent_title] => 'Antisense modulation of Fas mediated signaling' [patent_app_type] => new [patent_app_number] => 09/802669 [patent_app_country] => US [patent_app_date] => 2001-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22562 [patent_no_of_claims] => 126 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20020004490.pdf [firstpage_image] =>[orig_patent_app_number] => 09802669 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1181137 [patent_doc_number] => 06740750 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-25 [patent_title] => 'Expression systems for functional nucleic acid expression' [patent_app_type] => B1 [patent_app_number] => 09/763590 [patent_app_country] => US [patent_app_date] => 2001-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12130 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/740/06740750.pdf [firstpage_image] =>[orig_patent_app_number] => 09763590 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5908053 [patent_doc_number] => 20020142975 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-03 [patent_title] => 'ANTISENSE INHIBITOR OF RECQL4 EXPRESSION' [patent_app_type] => new [patent_app_number] => 09/792594 [patent_app_country] => US [patent_app_date] => 2001-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25035 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20020142975.pdf [firstpage_image] =>[orig_patent_app_number] => 09792594 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6861638 [patent_doc_number] => 20030092646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-15 [patent_title] => 'Method and reagent for the inhibition of CD20' [patent_app_type] => new [patent_app_number] => 09/780164 [patent_app_country] => US [patent_app_date] => 2001-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 38735 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20030092646.pdf [firstpage_image] =>[orig_patent_app_number] => 09780164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6242181 [patent_doc_number] => 20020045210 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-18 [patent_title] => 'Neuropeptide-like polypeptide zpep17' [patent_app_type] => new [patent_app_number] => 09/776795 [patent_app_country] => US [patent_app_date] => 2001-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 37895 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20020045210.pdf [firstpage_image] =>[orig_patent_app_number] => 09776795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6792503 [patent_doc_number] => 20030087847 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'Method and reagent for the inhibition of checkpoint kinase-1 (Chk1) enzyme' [patent_app_type] => new [patent_app_number] => 09/776474 [patent_app_country] => US [patent_app_date] => 2001-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 40880 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087847.pdf [firstpage_image] =>[orig_patent_app_number] => 09776474 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1580704 [patent_doc_number] => 06423488 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-23 [patent_title] => 'High throughput screening assay for detecting a DNA sequence' [patent_app_type] => B1 [patent_app_number] => 09/760048 [patent_app_country] => US [patent_app_date] => 2001-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8482 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/423/06423488.pdf [firstpage_image] =>[orig_patent_app_number] => 09760048 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7093738 [patent_doc_number] => 20010034329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-25 [patent_title] => 'Antisense modulation of focal adhesion kinase expression' [patent_app_type] => new [patent_app_number] => 09/757100 [patent_app_country] => US [patent_app_date] => 2001-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16142 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20010034329.pdf [firstpage_image] =>[orig_patent_app_number] => 09757100 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6290077 [patent_doc_number] => 20020055148 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-09 [patent_title] => 'Cloning method for DNA fragments using arbitrarily primed PCR' [patent_app_type] => new [patent_app_number] => 09/738769 [patent_app_country] => US [patent_app_date] => 2000-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4493 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20020055148.pdf [firstpage_image] =>[orig_patent_app_number] => 09738769 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1435839 [patent_doc_number] => 06355482 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Antisense inhibition of integrin beta 4 binding protein expression' [patent_app_type] => B1 [patent_app_number] => 09/716161 [patent_app_country] => US [patent_app_date] => 2000-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27121 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355482.pdf [firstpage_image] =>[orig_patent_app_number] => 09716161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1241349 [patent_doc_number] => 06683172 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-27 [patent_title] => 'Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy' [patent_app_type] => B1 [patent_app_number] => 09/647701 [patent_app_country] => US [patent_app_date] => 2000-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 870 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/683/06683172.pdf [firstpage_image] =>[orig_patent_app_number] => 09647701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1279920 [patent_doc_number] => 06646117 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-11 [patent_title] => 'Polyribozyme capable of conferring on plants resistance to viruses and resistant plants producing this polyribozyme' [patent_app_type] => B1 [patent_app_number] => 09/705014 [patent_app_country] => US [patent_app_date] => 2000-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 12796 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/646/06646117.pdf [firstpage_image] =>[orig_patent_app_number] => 09705014 [rel_patent_id] =>[rel_patent_doc_number] =>)